Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Retrovirology Year : 2009

Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome.

Dorine Cornet
  • Function : Author
  • PersonId : 918467
Catherine Dollfus
  • Function : Author
  • PersonId : 918468
Veronique Schneider
  • Function : Author
  • PersonId : 918469
Marianne Burgard
  • Function : Author
  • PersonId : 895838
Laurent Mandelbrot
  • Function : Author
  • PersonId : 918471


BACKGROUND: Primary-HIV-1-infection in newborns that occurs under antiretroviral prophylaxis that is a high risk of drug-resistance acquisition. We examine the frequency and the mechanisms of resistance acquisition at the time of infection in newborns. PATIENTS AND METHODS: We studied HIV-1-infected infants born between 01 January 1997 and 31 December 2004 and enrolled in the ANRS-EPF cohort. HIV-1-RNA and HIV-1-DNA samples obtained perinatally from the newborn and mother were subjected to population-based and clonal analyses of drug resistance. If positive, serial samples were obtained from the child for resistance testing. RESULTS: Ninety-two HIV-1-infected infants were born during the study period. Samples were obtained from 32 mother-child pairs and from another 28 newborns. Drug resistance was detected in 12 newborns (20%): drug resistance to nucleoside reverse transcriptase inhibitors was seen in 10 cases, non-nucleoside reverse transcriptase inhibitors in two cases, and protease inhibitors in one case. For 9 children, the detection of the same resistance mutations in mothers' samples (6 among 10 available) and in newborn lymphocytes (6/8) suggests that the newborn was initially infected by a drug-resistant strain. Resistance variants were either transmitted from mother-to-child or selected during subsequent temporal exposure under suboptimal perinatal prophylaxis. Follow-up studies of the infants showed that the resistance pattern remained stable over time, regardless of antiretroviral therapy, suggesting the early cellular archiving of resistant viruses. The absence of resistance in the mother of the other three children (3/10) and neonatal lymphocytes (2/8) suggests that the newborns were infected by a wild-type strain without long-term persistence of resistance when suboptimal prophylaxis was stopped. CONCLUSION: This study confirms the importance of early resistance genotyping of HIV-1-infected newborns. In most cases (75%), drug resistance was archived in the cellular reservoir and persisted during infancy, with or without antiretroviral treatment. This finding stresses the need for effective antiretroviral treatment of pregnant women.
Fichier principal
Vignette du fichier
1742-4690-6-85.pdf (375.9 Ko) Télécharger le fichier
1742-4690-6-85.xml (169.14 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Dates and versions

inserm-00663612 , version 1 (27-01-2012)



Constance Delaugerre, Marie-Laure Chaix, Stephane Blanche, Josiane Warszawski, Dorine Cornet, et al.. Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome.. Retrovirology, 2009, 6 (1), pp.85. ⟨10.1186/1742-4690-6-85⟩. ⟨inserm-00663612⟩
447 View
1384 Download



Gmail Facebook Twitter LinkedIn More